{"id":2908,"date":"2023-04-14T15:33:36","date_gmt":"2023-04-14T15:33:36","guid":{"rendered":"https:\/\/www.bioevents.net\/euroleuk2023\/?page_id=2908"},"modified":"2024-05-13T15:58:28","modified_gmt":"2024-05-13T15:58:28","slug":"congress-chair","status":"publish","type":"page","link":"https:\/\/dermato-oncology.com\/congress-chair\/","title":{"rendered":"Congress Chair"},"content":{"rendered":"
<\/span><\/p>\n Alexander M.M. Eggermont, MD, PhD Board of the Comprehensive Cancer Center Munich (CCCM), Technical University Munich & Ludwig Maximiliaan University Munich, \u00a0Munich, Germany.<\/span> International (current & past) scientific societal positions<\/u><\/strong><\/span><\/p>\n Professional awards (selection):<\/u><\/strong>\u00a0Joseph Maisin Chair in Oncology at Catholic University of Louvain in Belgium (2001); ASCO Statesman Award (2010); Michiel Van Vloten Award of the Dutch Surgical Society (2016); John Wayne Award of Clinical Research of Society Surgical Oncology (2018); Doctorate Honoris Causa (University Essen, Germany) (2018); Honorary Chair KAZIOR (Kazakh Institute of Oncology and Radiotherapy)(2019); Deutsche Krebshilfe Cancer Award (2019)<\/span><\/p>\n Specialties & Scientific Output<\/u><\/strong>:<\/u>\u00a0Clinical<\/strong>:\u00a0immunotherapy, melanoma<\/strong>, sarcoma,drug development.\u00a0Basic\/Translational<\/strong>: tumor immunology, animal models.\u00a0Scientific Output<\/strong>: >1000 publications; 36 PhD theses @ ErasmusMC: \u00a0H-index\/citations:\u00a0<\/strong>113, >61000 citations (Web of Science), \u00a0HI:115, >66000 (Scopus); HI:128, >80000 (Research Gate);\u00a0 HI:134, >93000 citations (Google Scholar)<\/span><\/p>\n Societal Awards:<\/u> \u00a0\u00a0\u00a0\u00a0\u00a0 L\u00e9gion d\u2019Honneur, France (2015)<\/strong><\/span><\/p>\n","protected":false},"excerpt":{"rendered":" Alexander M.M. Eggermont, MD, PhD Utrecht University, Netherlands Board of the Comprehensive Cancer Center Munich (CCCM), Technical University Munich & Ludwig Maximiliaan University Munich, \u00a0Munich, Germany. Chief Scientific Officer Princess M\u00e1xima Center for Pediatric Oncology, Utrecht, Netherlands\u00a0 Prof Clinical &Translational Immunotherapy, University Medical Center Utrecht, Netherlands. Coordinator Comprehensive Cancer Center Program Deutsche KrebsHilfe, Germany\u00a0 & […]<\/p>\n","protected":false},"author":8,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"footnotes":""},"acf":[],"yoast_head":"\n
\n<\/strong>Utrecht University, Netherlands<\/em><\/span><\/p>\n
\nChief Scientific Officer Princess M\u00e1xima Center for Pediatric Oncology, Utrecht, Netherlands\u00a0 Prof Clinical &Translational Immunotherapy, University Medical Center Utrecht, Netherlands.<\/span>
\nCoordinator Comprehensive Cancer Center Program Deutsche KrebsHilfe, Germany\u00a0 & Strategic Advisor @ DKFZ-NCT Heidelberg for National Center for Tumors Program, Germany.<\/span>
\nPast Director General, Gustave Roussy Cancer Campus Grand Paris, France (2010-2019) & Emeritus Professor Oncology, University Paris-Saclay, France (2012-2021).<\/span>
\nEmeritus Professor International Networking Cancer Research, ErasmusMC, Rotterdam, NL\u00a0 Emeritus Professor Surgical Oncology Erasmus University Rotterdam, NL.<\/span>
\nHonorary Professor Surgical Oncology, Catholic University Leuven, Belgium.<\/span>
\nFellow of USA NIH-NCI Surgery Branch (Steve Rosenberg) (85-86) PhD1987 TumorImmunology.<\/span><\/p>\n\n